The ICDDD 2008 is going to be the first major international conference and exhibition of this series, which aims to present cutting edge advances in various disciplines of drug design and discovery that have been recently achieved. Over 400 leading industrial and academic experts will present their findings in the form of lectures and poster presentations at this four-day conference. The ICDDD 2008 will offer an in-depth assessment of the challenges involved in the dynamic and fast moving field of drug discovery and development. It will bring together leading chemists, pharmacologists, biotechnologists, and other allied professionals to discuss and present the latest important developments in drug design and discovery.

The major topics of discussion related to drug design and discovery will include: Cancer; Cardiovascular Diseases; CNS; Pharmacogenomics; Protein & Peptides; Inflammation & Allergy; Drug Delivery & Safety; Drug Discovery Informatics; Drug Metabolism; Medicinal and Combinatorial Chemistry; Nanotechnology; Emerging Biomarkers & Drug Targets; Case Studies of Successful Drug Discovery and Development.

Dubai, the host city, is the region's business and tourism centre which is connected to all international markets. The city is also famous as the regional trading hub and gateway to the rest of the Middle East. The visitors coming to Dubai can enjoy a whole range of different experiences which includes elements of adventure, contrast, discovery and surprise. Dubai World Trade Center, the venue of the conference, offers a comprehensive range of facilities catering to all types of meetings and major international conventions.

Reasons to attend..
	"The anti-cancer section of the ICDDD will be devoted to a wide-ranging look at various modalities and approaches to cancer treatment and drug discovery. Open discussion, exchange of critical ideas, and face-to-face communication will be encouraged at all levels". Michael J. Waring Professor Department of Pharmacology University of Cambridge, UK
	"A great opportunity to learn more about the present and the future of Medicinal Chemistry" Patrice Talaga Associate Director Discovery Technologies Global Chemistry, R&D UCB, Belgium
	"Drug discovery is changing rapidly with the advent of new technology in chemistry and a "revolution" in molecular medicine, in particular regarding our molecular and genetic understanding of diseases. ICDDD 2008, therefore could not be more timely, pointing the directions into the future." Peter E. Nielsen Professor The Panum Institute University of Copenhagen, Denmark
	"The discovery and development of new biomarkers is a very active and rapidly evolving field. The ICDDD will provide an opportunity to bring together not only biomarker experts, but also scientists defining emerging drug targets. We expect that bringing together experts from both fields at the same time will result in a very fruitful and exciting session!" Stephen T. Furlong Director / Principal Scientist Discovery Medicine AstraZeneca, USA

Participating Nobel Laureates Zhores I. Alferov, Russia Nobel Prize - 2000 James Cronin, USA Nobel Prize - 1980 Johann Deisenhofer, USA Nobel Prize - 1988 Richard R. Ernst, Switzerland Nobel Prize - 1991 Robert Huber, Germany Nobel Prize - 1988 Klaus von Klitzing, Germany Nobel Prize - 1985 Sir Harold Kroto, UK Nobel Prize - 1996 Yuan T. Lee, Taiwan Nobel Prize - 1986 John Robert Schrieffer, USA Nobel Prize - 1972 Martinus J.G. Veltman, The Netherlands Nobel Prize - 1999 J. Robin Warren, Australia Nobel Prize - 2005 Kurt Wüthrich, USA Nobel Prize - 2002